Australian scientists will use new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24 million people globally, including 720,000 who die from leukemia, lymphoma or myeloma each year.
The Centre for Cancer Biology (CCB), an alliance between the University of South Australia and SA Pathology, has been awarded $1 million as part of a $2.5 million national genomic project led by the Walter and Eliza Hall Institute.
An international team of researchers will use new technologies to cross reference genomic data and speed up the diagnosis and treatment of blood, ovarian and breast cancers, thanks to the Medical Research Future Fund.
Section Head of the CCB Molecular Pathology Research Laboratory, Associate Professor Chris Hahn, says Adelaide researchers will focus on blood cancers, developing powerful new functional experiments to identify which genetic variants are harmful and which are benign.
